Author/Editor     Poles, Janez; Arzenšek, Nana
Title     "Euroheart" po Euroheart-u v Bolnišnici Topolšica leta 2003
Translated title     "Euroheart" after Euroheart in the Hospital of Topolšica in 2003
Type     članek
Source     In: Križman I, editor. Interna medicina 2005: novosti in aktualnosti. Zbornik predavanj 2. kongres Združenja internistov SZD; 2005 okt 21-22; Ljubljana. Ljubljana: Slovensko zdravniško društvo, Združenje internistov,
Publication year     2005
Volume     str. 261-7
Language     slo
Abstract     After the results of the "EuroHeart Failure Survey" were published last year in Eur Heart J, we wanted to check out how we treated our patients (pts) with heart failure in the Topolsica Hospital, what kind of diagnostics and treatment we used and how we deviated from the European guidelines. We studied 282 pts, dismissed from the hospital with the diagnosis of heart failure in 2003, aged 76 (from 45 to 99). Among pts there were 52.8% women. We analised medicaments which we prescribed and diagnostics procedures which were done. We compared our results with EU and Slovene hospitals, which participated in the Euro Heart Survey. We prescribed 5 medicaments in average (from 3 to 11). 81% of the pts got ACE inhibitors, 75% furosemid, 52% beta blockers, 31% digitalis, 30% spironolaktone, 28% nitrates and 89% of pts take warfarin or Aspirin. Combination of two medicaments with neurohormonal effects received 54% pts. All pts had done EKG. X-ray analysis of the chest had been done in 96%, ultrasound in 70%, ergospirometry in 4.6 and coronarography in 3%. We were interested also in the diseases, which frequently appear at heart failure. Results show that we follow the European guidelines adequatly. In presribing the first five drugs on the list we have better results as other comparative Slovene hospitals; in presribing of ACE inhibitors, BB and spironolactone even better than EU, but we have to respect the time gap. We are pleased that we do not lag behind EU in the diagnostic field. The numbers of ergospirometry are even larget than in EU. A small number of coronarography is the consequence of the narrow bottleneck of this diagnostics in Slovenia. We are less pleased with the reaching of target doses with ACE inhibitors and BB.
Descriptors     HEART FAILURE, CONGESTIVE